Suzdak Peter David 4
4 · AEOLUS PHARMACEUTICALS, INC. · Filed May 10, 2013
Insider Transaction Report
Form 4
Suzdak Peter David
Director
Transactions
- Award
Non-qualified Stock Option (right to buy)
2013-05-08+75,000→ 75,000 totalExercise: $0.44From: 2013-05-08Exp: 2013-08-08→ Common Stock (75,000 underlying)